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Abstract
Background: Anthropometric measurements including body mass index (BMI) and body adiposity index (BAI) are widely
employed as indicators of fat mass (FM). Metabolic abnormalities in amyotrophic lateral sclerosis (ALS) impact disease
progression, therefore assessment of FM informs care. The aim of this study was to determine whether BMI and BAI are
accurate predictors of FM in ALS. Methodology and main findings: BMI, BAI and percentage FM (determined by air
displacement plethysmography; FM-ADP) were measured in control (n¼ 35) and ALS (n¼ 44) participants. While BMI
and BAI correlated significantly with FM-ADP, neither index provided an accurate estimate of FM. In longitudinally
assessed ALS participants (n¼ 29; six-month repeat assessment interval), although a change in BMI (r2¼ 0.62 r¼ 0.79
p50.01) and BAI (r2¼ 0.20 r¼ 0.44, p¼ 0.02) correlated with a change in FM-ADP, the anthropometric measures did not
consistently reflect increases or decreases observed in FM-ADP. Conclusions/significance: Using FM-ADP as the standard,
this study suggests that BMI and BAI are not accurate measures of FM in ALS. Furthermore, longitudinal assessments
indicate that changes in BMI and BAI do not consistently reflect true changes of FM in ALS.
Keywords: Amyotrophic Lateral Sclerosis; adiposity; fat mass; body adiposity index; body mass index; air displacement
plethysmography; metabolic assessment
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal
neurodegenerative disease characterised by the
loss of motor neurons, resulting in progressive
muscle weakness. Clinical studies in ALS have
revealed adiposity to be a predictor of ALS mortality
(1), disease progression (2), and survival (3).
As such, there is increasing interest in preventing
loss of fat mass (FM) in ALS via nutritional
intervention (4–7). To optimise nutritional manage-
ment strategies, accurate measures of adiposity
are critical. Anthropometric measurements are
used to predict adiposity (8), and could serve as
convenient predictors of FM in ALS patients,
especially as disability may limit use of other
measures of FM, such as dual-energy X-ray absorp-
tiometry (DEXA) or magnetic resonance imaging
(MRI).
Common anthropometric measurements of FM
include body mass index (BMI) (9) and body
adiposity index (BAI) (10). BMI is an inaccurate
predictor of FM in populations with altered lean
mass (11,12), so given the decline in muscle mass
seen in ALS, BMI might be expected to be unre-
liable. BAI has been proposed as a more robust
method of predicting FM (10). However, altered fat
distribution in ALS (13,14) could affect BAI.
Moreover, BAI may not provide valid estimates of
body fat in lean individuals (15), a group commonly
identified in ALS (16). In this study, we assessed the
accuracy of BMI and BAI in predicting FM in ALS
participants and age- and gender-matched controls,
using air displacement plethysmography (ADP) as
the standard. We also determined how accurately a
change in BMI and BAI reflects a change in FM in
ALS participants.
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Methodology
Forty-four ALS participants who met the revised El
Escorial criteria for probable or definite ALS (17)
were recruited from the Royal Brisbane and
Women’s Hospital (RBWH) ALS clinic. Of these,
29 ALS participants underwent a second assess-
ment (six-months interval; mean 5.65 0.40,
range of 2.80–9.73 months). Age- and gender-
matched healthy control participants (n¼ 35) were
also assessed. Controls were recruited as a con-
venience sample of spouses, friends or family
members of ALS participants. This study was
approved by the University of Queensland and
The RBWH human research ethics committees.
Written informed consent was obtained from all
participants prior to assessments. Following a 12-h
overnight fast, participants presented for assess-
ment of BMI, BAI and whole-body composition
via ADP (18). Demographic data are shown in
Table 1.
Anthropometric and body composition measures
Body mass was determined to the nearest 0.001 kg
(Cosmed USA Inc., Chicago, IL). Hip
circumference was measured to the nearest 0.5 cm
following established guidelines (19). Height was
measured to the nearest 0.5 cm with a wall-mounted
stadiometer (Novel Products Inc., Rockton, IL).
BMI was calculated as body mass divided by height
squared (kg/m2). BAI was calculated from height
and hip circumference as described previously (10).
Body composition was determined by the BodPod
system (Cosmed USA Inc.) using standardised
procedures (20). Following measurement of body
mass, two body volume measurements were taken
with participants wearing underwear and swimming
cap. The predicted thoracic gas volume was sub-
tracted to give the non-gas body volume and,
following calculation of body density, FM and fat
free mass (FFM) were determined by the Bodpod
software using the Siri algorithm (21).
Statistical methods
Statistical analysis was performed using Prism soft-
ware version 7 (Graphpad Inc., La Jolla, CA).
Linear regression was used to examine the relation-
ship between each anthropometric measurement
(BMI and BAI) and %FM-ADP. The agreement
Table 1. Participant demographics and metrics.
Control ALS (1st measure) ALS (2nd measure) p Value
Baseline assessments
Number of participants 35 44
Participant demographics
Male:Female (n) 25:10 (71.43% male) 32:12 (72.73% male)
Age at assessment (years) 59.48 (46.64–73.74) 61.09 (46.02–79.55) 0.37
Age of males (years) 59.35 (46.64–73.74) 59.49 (46.02–79.55) 40.99
Age of females (years) 59.86 (52.78–66.54) 65.37 (55.79–74.83) 0.23
Time Since Diagnosis (months) 9.90 (0.77–47.00)
ALSFRS-R (out of 48) 38.50 (28.00–46.00)
Composition Metrics (1st visit)
Body Mass (kg) 82.23 (50.61–119.90) 76.37 (52.19–112.80) 0.12
BMI (kg/m2) 26.65 (17.93–37.25) 25.64 (19.17–34.13) 0.28
Hip circumference (cm) 98.91 (81.00–123.00) 98.75 (81.00–116.00) 0.94
BAI 24.84 (16.42–43.25) 25.93 (15.96–37.39) 0.34
FM-ADP (%) 30.55 (10.00–53.60) 34.01 (7.20–55.60) 0.15
FM-ADP (kg) 26.89 (5.07–57.97) 26.49 (5.63–51.46) 0.88
Serial assessments
Number of participants 29 29
Participant demographics
Male:Female (n) 22.7 (75.86% male) 22:7 (75.86% male)
Age at assessment (years) 60.60 (46.04–79.55) 61.06 (46.49–79.82)
Time Since Diagnosis (months) 10.84 (0.90–47.10) 16.48 (4.60–51.07)
ALSFRSR (out of 48) 38.48 (28–45. 36.79 (26.0–45.0) 50.01
Composition Metrics
Body Mass (kg) 77.01 (55.50–112.80) 76.36 (55.64–114.90) 0.43
BMI (kg/m2) 25.45 (20.18–34.13) 25.25 (18.10–34.78) 0.46
Hip circumference (cm) 97.12 (81.00–116.00) 97.91 (82.50–114.00) 0.42
BAI 24.70 (15.96–35.63) 25.40 (15.93–36.80) 0.04
FM-ADP (%) 33.07 (11.70–50.40) 32.90 (7.70–49.80) 0.82
FM-ADP (kg) 25.81 (6.94–51.46) 25.66 (4.42–49.84) 0.82
Data presented as mean (range). ALSFRS-R: Amyotrophic Lateral Sclerosis Functional Rating Scale; BMI: body mass index; BAI: body
adiposity index; FM ADP: fat mass determined by air displacement plethesmography; p values for age comparisons between males and
females specific to ALS and controls by ordinary one-way ANOVA with Bonferroni’s multiple comparison test. All other p values by
Student’s t-test (unpaired for baseline assessments, paired for serial assessments).
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between each anthropometric measure and %FM-
ADP was assessed by the Bland-Altman approach,
in which the difference versus the mean of the
two methods was plotted for each participant.
Bland-Altman analysis evaluates the bias between
the mean differences of the two methods, and
estimates an agreement interval, within which 95%
of the differences of one method, compared to the
other fall (22). In each case the plotted results
were compared to the line of equality, which
reflects complete agreement between methods.
The change in BMI, BAI and %FM-ADP between
longitudinal assessments was calculated and linear
regression was used to examine the strength of the
relationship between a change in BMI and BAI
versus %FM-ADP.
Results
Composition metrics in the control and ALS cohorts
No significant differences in FM-ADP, BMI or BAI
between ALS and control cohorts were observed
(Table 1). Although there was a trend towards lower
body mass and higher %FM-ADP in the ALS
cohort, this did not reach statistical significance
(Table 1).
A significant positive correlation was observed
between BMI and %FM-ADP (Figure 1(A), in
controls r2¼ 0.34; r¼ 0.59; p50.01, in ALS
r2¼ 0.29; r¼ 0.54; p50.01) and BAI and %FM-
ADP (Figure 1(B), in controls r2¼ 0.61; r¼ 0.78;
p50.01, in ALS r2¼ 0.56; r¼ 0.75; p50.01).
Regression slopes for BMI (p¼ 0.03, Figure 1(A))
and BAI (p¼ 0.04 Figure 1(B)) versus %FM-ADP
were significantly different between the control and
ALS cohorts.
Using Bland Altman analysis we observed a
positive mean bias (MB) with BMI (Control ¼4.22
and ALS ¼8.38) and BAI (Control ¼5.91 and ALS
¼8.08) compared to %FM-ADP, particularly as
percentage FM increased (Figure 1(C–F)). A
greater 95% confidence interval of limits was
observed for the ALS analyses (–12.14 to 28.89
for BMI comparisons and –9.06 to 25.23 for BAI
comparisons, Figure 1(E,F)) relative to controls
(–7.41 to 15.84 for BMI comparisons and –3.22 to
15.04 for BAI comparisons Figure 1(C,D), suggest-
ing that both anthropometric measurements are
worse predictors of FM in ALS compared to healthy
matched controls.
Longitudinal assessment
Twenty-nine ALS participants were re-assessed six
months following initial screening (Table 1 and
Supplementary table). Mean BMI, BAI and FM-
ADP did not differ between assessments, principally
as individuals (male in blue, females in red)
presented with an increase or decrease in
%FM-ADP (Figure 2(A) and Supplementary
table), BMI, and BAI (Figure 2(B) and
Supplementary table). A stronger correlation was
observed for a change in BMI versus a change in
%FM-ADP (Figure 2(C); r2¼ 0.62 r¼ 0.79
p50.01) compared to a change in BAI versus a
change in %FM-ADP (Figure 2(D); r2¼ 0.20
r¼ 0.44 p¼ 0.02). There was a wide range of
change in FM-ADP over the  six-month interval,
ranging from the loss of 9.36 kg fat to a gain of
6.96 kg fat (Supplementary table). The change in
FM-ADP was not consistently reflected by either
anthropometric measure and in some individuals the
direction of change of BMI and BAI was opposite to
the direction of change in FM-ADP (Figure 2(C,D),
Supplementary table).
Discussion
Using ADP, a reliable and reproducible method for
determining body composition (23–25), we com-
pared the accuracy of BMI and BAI in predicting
adiposity in ALS relative to a non-ALS population
at baseline, and in ALS over time.
While BMI and BAI were correlated with FM-
ADP, Bland-Altman analysis revealed a lack of
agreement between both anthropometric measures
and FM-ADP. Given that BMI and BAI had a
positive bias, particularly as percentage FM
increased, our results imply that BMI and BAI are
not accurate indicators of adiposity in ALS. In a
longitudinal assessment of FM in ALS participants,
a change in BMI and BAI correlated with a change
in %FM-ADP. The strength of this relationship was
greater for changes in BMI; however, neither BMI
nor BAI consistently reflected changes in FM-ADP.
The relationship between BMI, BAI and FM is
complex and dependent on the extent and distribu-
tion of adiposity in the individual. For example, BAI
might over- or under-estimate FM in individuals
with lower or higher levels of adiposity, respectively
(10). Our study suggests that BMI and BAI are not
accurate measures of FM in ALS. This is in line with
studies in obese individuals (26) and healthy sed-
entary females (27), which found limitations asso-
ciated with anthropometric measures as a marker of
FM. The observed deviation in the relationship
between anthropometric measures and FM between
control and ALS participants, suggests that factors
specific to ALS might impact the accuracy of
anthropometric measures as predictors of FM. Hip
circumference (the key determinant of BAI and
generally accepted as a proxy for abdominal adipos-
ity (10)) could be affected by factors intrinsic to the
disease process in ALS. For example, redistribution
of fat to the abdomen (13,14) might impact hip
circumference, and thus predictions of BAI.
Moreover, a loss of lean mass secondary to neuro-
genic muscle wasting might also influence weight
Anthropometric measures are not accurate predictors of fat mass in ALS 3
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changes and consequently affect BMI. Overall,
changes in BMI and BAI are likely to be the result
of changes in body composition that could vary
independently in ALS depending on the rate of
muscle atrophy and on the state of nutritional
balance.
Given that adiposity is a predictor of ALS
mortality (1), progression (2), and survival (3), our
study shows that anthropometric measures of FM
need to be interpreted with caution in ALS. This is
of clinical significance as inaccurate estimation of
FM or misleading estimates of changes in FM over
time in ALS could have critical implications in
misdirecting nutritional interventions aimed at
maintaining adequate energy homeostasis.
Limitations of this study include potential error
associated with the use of ADP as the criterion.
Clinical studies suggest that ADP and DEXA agree
within 1% body fat (18); however, this relationship
has not been studied in ALS. In our study ADP was
selected for measurement of FM as many ALS
patients are unable to lie flat due to respiratory
Figure 1. Use of BMI and BAI to predict adiposity in control and ALS participants. Linear regression showing 95% confidence band of
line of best fit for BMI (A) and BAI (B) versus %FM-ADP in control and ALS participants. The lines of best fit are compared to the line of
equality (red line). Bland–Altman plots for control (C and D) and ALS (E and F) participants illustrating the difference between, and
average of %FM-ADP versus BMI (C and E) and BAI (D and F). The mean bias (MB; broken red line) illustrates the average discrepancy
between methods. Broken grey lines illustrate the 95% confidence interval of limits of agreement (mean bias 2 STD). Abbreviations:
ALS: amyotrophic lateral sclerosis; BMI: body mass index; BAI: body adiposity index; FM-ADP: fat mass determined by air displacement
plethysmography; MB: mean bias.
4 Z. A. Ioannides et al.
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impairment, which could preclude the use of DEXA
or MRI. Error was minimised by adherence to a
strict protocol to minimise extracorporeal volume.
Due to the progressive nature of ALS, our longitu-
dinal assessments were limited to 29 individuals.
Replication of these finding in a larger cohort of
participants is needed.
To conclude, our study suggests that BMI and
BAI do not provide an accurate estimate of FM in
ALS. Similarly, serial anthropometric measure-
ments could be misleading in estimating a change
in FM over time. Knowledge of these limitations in
using BMI and BAI in ALS in the absence of more
reliable measures of FM will aid nutritionists and
clinicians to optimise nutritional and dietary man-
agement strategies in ALS.
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Figure 2. Use of BMI and BAI to predict a change in adiposity in ALS participants over time. Scatter plots showing change in %FM-ADP
(A) and BMI and BAI (B) for ALS participants at second assessment relative to first assessment. Linear regression showing 95%
confidence band of line of best fit for change in BMI (C) or change in BAI (D) relative to change in the %FM-ADP in ALS participants.
Female and male participants are indicated in red and blue respectively. Abbreviations: ALS: amyotrophic lateral sclerosis; BMI: body
mass index; BAI: body adiposity index; FM-ADP: fat mass determined by air displacement plethysmography.
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